v3.26.1
Consolidated statement of income (loss) - EUR (€)
€ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Consolidated statement of income (loss)      
Revenues € 4,483 € 9,198 € 17,477
Other income 3,443 5,526 5,686
Total revenues and other income 7,926 14,725 23,163
Research and development costs (87,043) (90,880) (110,012)
Marketing - Business development expenses (4,963) (1,953) (1,980)
General and administrative expenses (47,895) (15,839) (13,837)
Other operating income (expenses) (9,039) (3,609) (44)
Operating profit (loss) (141,013) (97,558) (102,709)
Financial income 4,169 2,888 1,788
Financial expenses (216,922) (88,917) (6,882)
Financial income (loss) (212,752) (86,029) (5,095)
Share of net profit (loss) - Equity method (350) (313) (2,015)
Income tax (22) (313) (607)
Net loss for the period € (354,138) € (184,212) € (110,426)
Basic loss per share € (1.9) € (3.08) € (2.43)
Diluted loss per share € (1.9) € (3.08) € (2.43)
Weighted average number of shares outstanding used to calculate basic loss per share 186,801,792 59,778,701 45,351,799
Weighted average number of shares outstanding used to calculate diluted loss per share 186,801,792 59,778,701 45,351,799